Cargando…

Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation

Liver cancer is the third most common cause of cancer related death in the World. From an epidemiological point of view the risk factors associated to primary liver cancer are mainly viral hepatitis infection and alcohol consumption. Even though there is a clear correlation between liver inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sällberg, Matti, Pasetto, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119224/
https://www.ncbi.nlm.nih.gov/pubmed/32292409
http://dx.doi.org/10.3389/fimmu.2020.00552
_version_ 1783514733009174528
author Sällberg, Matti
Pasetto, Anna
author_facet Sällberg, Matti
Pasetto, Anna
author_sort Sällberg, Matti
collection PubMed
description Liver cancer is the third most common cause of cancer related death in the World. From an epidemiological point of view the risk factors associated to primary liver cancer are mainly viral hepatitis infection and alcohol consumption. Even though there is a clear correlation between liver inflammation, cirrhosis and cancer, other emerging liver diseases (like fatty liver) could also lead to liver cancer. Moreover, the liver is the major site of metastasis from colon, breast, ovarian and other cancers. In this review we will address the peculiar status of the liver as organ that has to balance between tolerance and immune activation. We will focus on macrophages and other key cellular components of the liver microenvironment that play a central role during tumor progression. We will also discuss how current and future therapies may affect the balance toward immune activation.
format Online
Article
Text
id pubmed-7119224
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71192242020-04-14 Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation Sällberg, Matti Pasetto, Anna Front Immunol Immunology Liver cancer is the third most common cause of cancer related death in the World. From an epidemiological point of view the risk factors associated to primary liver cancer are mainly viral hepatitis infection and alcohol consumption. Even though there is a clear correlation between liver inflammation, cirrhosis and cancer, other emerging liver diseases (like fatty liver) could also lead to liver cancer. Moreover, the liver is the major site of metastasis from colon, breast, ovarian and other cancers. In this review we will address the peculiar status of the liver as organ that has to balance between tolerance and immune activation. We will focus on macrophages and other key cellular components of the liver microenvironment that play a central role during tumor progression. We will also discuss how current and future therapies may affect the balance toward immune activation. Frontiers Media S.A. 2020-03-27 /pmc/articles/PMC7119224/ /pubmed/32292409 http://dx.doi.org/10.3389/fimmu.2020.00552 Text en Copyright © 2020 Sällberg and Pasetto. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Sällberg, Matti
Pasetto, Anna
Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
title Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
title_full Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
title_fullStr Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
title_full_unstemmed Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
title_short Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
title_sort liver, tumor and viral hepatitis: key players in the complex balance between tolerance and immune activation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119224/
https://www.ncbi.nlm.nih.gov/pubmed/32292409
http://dx.doi.org/10.3389/fimmu.2020.00552
work_keys_str_mv AT sallbergmatti livertumorandviralhepatitiskeyplayersinthecomplexbalancebetweentoleranceandimmuneactivation
AT pasettoanna livertumorandviralhepatitiskeyplayersinthecomplexbalancebetweentoleranceandimmuneactivation